Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A. Dhayat, Daniel G. Fuster, Giulia Bedino et al.|BMC Nephrology|2018Cited by 33
Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trialSimeon Schietzel, Daniel G. Fuster, Lia Bally et al.|BMJ Open|2022Cited by 31
Indapamide or chlorthalidone to reduce urine supersaturation for secondary prevention of kidney stones: protocol for a randomised, double-blind, cross-over trial (INDAPACHLOR)Martin Scoglio, Daniel G. Fuster, Matteo Bargagli et al.|BMJ Open|2025Cited by 2